Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation

Fig. 4

Screening and validation of hub genes. a, b Univariate and multivariate analysis of overall survival rate of ccRCC patients. c–h Tissue expression difference analysis and survival analysis of three hub genes based on the TCGA cohort. i TEK mRNA expression difference was analyzed based on GSE53757 dataset. j Correlation analysis between TEK and pathological stages (based on GSE53757 dataset). k, l Analyze the differential expression of TEK in tumor and adjacent tissues by qPCR and IHC experiments

Back to article page
\